EUCTR2015-002408-97-ES进行中（未招募）1 期
Comparative Study, intraindividual to evaluate efficacy and safety of the treatment of actinic keratosis with photodinamic therapy between methyl aminolevulinate cream and aminolevulinic acid nanosome gel
Dr. Carlos Serra0 个研究点开始时间: 2015年10月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Eligible patients may present at least 5 QA in two symmetrical areas of the face or the scalp. Can not be significant differences in the number QAs between the two treatment areas.
- •1. Patients older than 18 years and able to give informed consent.
- •2. Patients must have at least 5 QA in two symmetrical areas of the face or the scalp.
- •3. Patients must no use solar protection creams or other creams (retinoic, hydroxiacids, emollients, topic antibiotics) on the treatment area during the study time.
- •4. Patients must agree to postpone the treatment of the other actinic keratosis lesions close to the treatment area.
- •5. Patients must agree going to the scheduled visits where they have to complete a form with epidemiology aspects, baseline characteristics, and satisfaction with the treatment received and taking pictures of the treatment area on each visit.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Perioral and periocular areas of the face will be discarded as treatment zones. Patients with previous treatment with photodynamic therapy in the face or the scalp for any lesion. Patients with previous treatment for actinic keratosis in the previous 3 months, patients with inmunosuppression treatment, and patients with inherited diseases which can predispose to cutaneous cancer (Gorlin syndrome, xeroderma pigmentosum.
- •1. Patients who have clinical evidence of inmunosuppression, unstable cardiovascular diseases, haematological, hepatic, neurological, renal or endocrine diseases. Patients with stables medical conditions like high blood pressure. diabetes mellitus, hypercholesterolemia, etc. can be included in the study.
- •2. Patients who suffer form any dermatological disease in the treatment zone or around it.
- •3. Patients who have received previous treatment with photodynamic therapy in the selected areas.
- •4. Patients who have alcohol or drug dependency.
- •5. Being currently participating in other studies
- •6. Patients who have received any of the following treatments in less time than indicated:
- •- Systemic chemotherapy, in the last 6 months
- •- Systemics retinoids, interferon, inmunomodulators or inmunosuppressors, cytotoxic agents, systemic corticoids, in the last month
- •- PUVA, UVB, ablative lasers, dermabrasion, chemical peelings, in the last 6 months
- •- Topic retinoids, topic 5-fluorouracil, in the last month.
- •- Cryotherapy, surgical extirpation, curettage, topic corticoids, in the last month
研究者
相似试验
尚未招募
不适用
A study to compare the individual and combined effect of nerve flossing technique and intermittent lumbar traction on Pain and disability in lumbar radiculopathy patients.CTRI/2019/02/017840Government physiotherapy collegeJamnagar
尚未招募
2 期
Management of Polycystic Ovarian Syndrome by AyurvedaCTRI/2022/08/045045Principal RGGPG Ayurvedic College and Hospital Paprola
尚未招募
不适用
a clinical study to evaluate the comparative effect of shatavari and ashwagandha on shukra kshayaCTRI/2021/09/036415Government ayurvedic college patiala
尚未招募
2 期
A Comparative Clinical study to see the effect of some Ayurvedic formulation in patients of itching in vulvaCTRI/2021/03/032120State Ayurvedic College and Hospital lucknow
尚未招募
Unknown
Comparative Effect of Basti therapy of Ayurveda in chronic kidney disease treatmentCTRI/2024/07/070318All India Institute of Ayurveda (AIIA)